OTCMKTS:PRVCF

PreveCeutical Medical (PRVCF) Stock Forecast, Price & News

$0.02

0.00 (0.00%)

(As of 06/8/2023 ET)

Compare

Today's Range: $0.02
▼
$0.02
50-Day Range: $0.02
▼
$0.02
52-Week Range: $0.01
▼
$0.03

Volume: 47 shs
Average Volume: 34,693 shs
Market Capitalization: $11.67 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Profile Chart Competitors Headlines Short Interest

About PreveCeutical Medical (OTCMKTS:PRVCF) Stock

PreveCeutical Medical, Inc. engages in licensing, branding, and marketing of nutraceutical and wellness products. The company was founded by Stephen Van Deventer, Kimberly Van Deventer, Greg Reid, Shabira Rajan, Mak Jawadekar, Harry Parekh, Nicole Goncalves-Krysinski, Lish Rebman, and Sydney Cole on December 15, 2014 and is headquartered in Vancouver, Canada.

Receive PRVCF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PreveCeutical Medical and its competitors with MarketBeat's FREE daily newsletter.

PRVCF Stock News Headlines

May 30, 2023 | finance.yahoo.com

PreveCeutical Medical - Sol-Gel and Uses thereof Patent Update

April 24, 2023 | finance.yahoo.com

PreveCeutical Medical Launches Clinical Artificial Intelligence Division

June 9, 2023 | Edge On The Street (Ad)

All Electric Commitment From GM, Volkswagen, Could Put Lithium Sector In A Supercycle

More automakers are pledging to go "fully electric" by 2035. NOW is the perfect time to get in on the "EV Revolution." And the best way to potentially do that, is to skip over the overvalued electric vehicle stocks...

April 20, 2023 | finance.yahoo.com

PreveCeutical Medical Announces Live Interactive Q&A Video Conference

April 4, 2023 | finance.yahoo.com

PreveCeutical Medical Announces Frontiers Media SA Publication Featuring Data from its Analgesic Program for the Treatment of Peptide-based Therapeutics for Moderate to Severe Pain

March 20, 2023 | finance.yahoo.com

PreveCeutical Initiates Non-Analgesic (Painkiller) Program, Clinical Development Program & Disclosure Committee

February 23, 2023 | seekingalpha.com

PRVCF PreveCeutical Medical Inc.

February 21, 2023 | finance.yahoo.com

Appointment of C. Evan Ballantyne to PreveCeutical's Board of Directors

June 9, 2023 | Edge On The Street (Ad)

All Electric Commitment From GM, Volkswagen, Could Put Lithium Sector In A Supercycle

February 7, 2023 | finance.yahoo.com

PreveCeutical Awards ICON Analgesic Program (Painkiller) Clinical Development

January 14, 2023 | msn.com

PreveCeutical, Endosane team up for sol-gel tech use in cannabis therapy

January 12, 2023 | finance.yahoo.com

PreveCeutical Enters into License Option Agreement with Endosane Pharmaceuticals

January 9, 2023 | finance.yahoo.com

PreveCeutical Signs Intercompany Sol-Gel License Agreement

November 23, 2022 | finance.yahoo.com

The Power Play by The Market Herald Releases New Interviews with Eloro Resources, Prospera, Datametrex, Gamelancer Media, Infinity Stone Ventures and PreveCeutical Medical Discussing Their Latest News

November 21, 2022 | finance.yahoo.com

PreveCeutical Files Application for D-amino Acid Peptides

November 12, 2022 | finanznachrichten.de

PreveCeutical Medical Inc.: PreveCeutical Announces Conversion of Debt

November 12, 2022 | finance.yahoo.com

PreveCeutical Announces Conversion of Debt

October 20, 2022 | finance.yahoo.com

Appointment of Kathleen Rotika to PreveCeutical's Board of Directors

September 17, 2022 | finance.yahoo.com

PreveCeutical Announces Resignation of Board of Director Member

September 6, 2022 | finance.yahoo.com

Appointment of Sachin Nanavati to PreveCeutical's Board of Directors

May 27, 2022 | finance.yahoo.com

PreveCeutical Announces Change in Directors and Investor Awareness Services

May 9, 2022 | finance.yahoo.com

Article Based on PreveCeutical's Pain Management Peptides Program Published in the British Journal of Pharmacology

November 29, 2021 | finance.yahoo.com

PreveCeutical Files International Patent Application for Sol-Gel Cannabinoid Formulation for Antiviral Use

November 24, 2021 | finance.yahoo.com

PreveCeutical Files Provisional Patent Application for D-Amino Acid Peptides

November 18, 2021 | finance.yahoo.com

PreveCeutical Signs License Agreement for Exclusive Rights to Use UniQuest's Sol-Gel Technology for Delivery of Cannabinoids

August 31, 2021 | finance.yahoo.com

PreveCeutical Receives AU$315,338 Research & Development Tax Incentive Cash Refund

March 17, 2021 | ca.finance.yahoo.com

PREVECEUTICAL MED. (18H.BE)

See More Headlines

PRVCF Price History

30 days | 90 days | 365 days | Advanced Chart

PRVCF Company Calendar

Today: 6/09/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Private households
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:PRVCF
CUSIP: N/A
CIK: N/A
Web: www.preveceutical.com
Phone: (604) 416-7777
Fax: 778-945-6290
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($0.01) per share
Price / Book: -2.18

Miscellaneous

Outstanding Shares: 535,300,000
Free Float: N/A
Market Cap: $11.67 million
Optionable: Not Optionable
Beta: 0.87

Key Executives

Stephen van Deventer
Chairman, Chief Executive & Financial Officer

Makarand Jawadekar
President, Director & Chief Science Officer

Harry Parekh
Chief Research Officer

Alicia Rebman
Marketing Director

Key Competitors

View All Competitors

PRVCF Stock - Frequently Asked Questions

How have PRVCF shares performed in 2023?: PreveCeutical Medical's stock was trading at $0.0179 on January 1st, 2023. Since then, PRVCF shares have increased by 21.8% and is now trading at $0.0218.
View the best growth stocks for 2023 here.
What is PreveCeutical Medical's stock symbol?: PreveCeutical Medical trades on the OTCMKTS under the ticker symbol "PRVCF."

How do I buy shares of PreveCeutical Medical?: Shares of PRVCF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is PreveCeutical Medical's stock price today?: One share of PRVCF stock can currently be purchased for approximately $0.02.
How much money does PreveCeutical Medical make?: PreveCeutical Medical (OTCMKTS:PRVCF) has a market capitalization of $11.67 million.
How can I contact PreveCeutical Medical?: PreveCeutical Medical's mailing address is 1177 West Hastings Street Suite 2200, Vancouver A1, V6E2K3. The official website for the company is www.preveceutical.com. The company can be reached via phone at (604) 416-7777, via email at ir@preveceutical.com, or via fax at 778-945-6290.

This page (OTCMKTS:PRVCF) was last updated on 6/9/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial